Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-015052
Filing Date
2023-02-28
Accepted
2023-02-28 09:15:38
Documents
1
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea174405-6k_regencell.htm 6-K 10668
  Complete submission text file 0001213900-23-015052.txt   11756
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-40617 | Film No.: 23678908
SIC: 2833 Medicinal Chemicals & Botanical Products